Neuroblastoma Treatment (PDQ®): Health Professional Version
- PMID: 26389190
- Bookshelf ID: NBK65747
Neuroblastoma Treatment (PDQ®): Health Professional Version
Excerpt
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of neuroblastoma. It is intended as a resource to inform and assist clinicians in the care of their patients. It does not provide formal guidelines or recommendations for making health care decisions.
This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH).
Keywords: neuroblastoma.
Sections
- General Information About Neuroblastoma
- Histological Classification of Neuroblastic Tumors
- Neuroblastoma Staging and Risk Classification Systems
- Genomic and Biological Features of Neuroblastoma
- Special Considerations for the Treatment of Children With Cancer
- Treatment Option Overview for Neuroblastoma
- Treatment of Non–High-Risk Neuroblastoma
- Treatment of High-Risk Neuroblastoma
- Treatment of INSS Stage 4S and INRG Stage MS Neuroblastoma
- Treatment of Recurrent or Refractory Neuroblastoma
- Latest Updates to This Summary (04/28/2025)
- About This PDQ Summary
References
-
- Childhood cancer by the ICCC. In: Howlader N, Noone AM, Krapcho M, et al., eds.: SEER Cancer Statistics Review, 1975-2010. National Cancer Institute, 2013, Section 29. Also available online. Last accessed August 21, 2023.
-
- National Cancer Institute: NCCR*Explorer: An interactive website for NCCR cancer statistics. Bethesda, MD: National Cancer Institute. Available online. Last accessed February 25, 2025.
-
- Childhood cancer. In: Howlader N, Noone AM, Krapcho M, et al., eds.: SEER Cancer Statistics Review, 1975-2010. National Cancer Institute, 2013, Section 28. Also available online. Last accessed August 21, 2023.
-
- Surveillance Research Program, National Cancer Institute: SEER*Explorer: An interactive website for SEER cancer statistics. Bethesda, MD: National Cancer Institute. Available online. Last accessed December 30, 2024.
Publication types
LinkOut - more resources
Full Text Sources